Hello and Welcome to Patientsville.com, Your Source for all NEORAL information. We are dedicated to provide You with NEORAL safety information. Learn about NEORAL serious adverse events reported to Food and Drug Administration (FDA).
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
NEORAL Safety Reports
Total NEORAL reports: 379.NEORAL FDA safety alerts: No.
Reported deaths: 78 Reported hospitalizations: 213.
Take NEORAL Side Effects Survey or Share Your NEORAL Story. Read More Here.
Showing 1-75 of 379 Next >
Physician from CANADA reported NEORAL problem on Mar 27, 2007. Male patient, 54 years of age, was diagnosed with liver transplant and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, aggression, anorexia, apathy, delirium, hepatic encephalopathy, mutism, neurotoxicity. NEORAL dosage: 550 MG / DAY. Patient was hospitalized. Patient recovered.NEORAL problem was reported by a Consumer or non-health professional from JAPAN on Mar 28, 2007. Male patient, 39 years of age, was diagnosed with renal transplant and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: calculus ureteric, complications of transplanted kidney, dialysis, haemodialysis, hydronephrosis, nephropathy toxic, nephrostomy, oliguria, postrenal failure. NEORAL dosage: 200 MG/D. During the same period patient was treated with DENOSINE, PROGRAF, CELLCEPT. Patient was hospitalized. Patient recovered.
Physician from NEW ZEALAND reported NEORAL problem on Mar 26, 2007. Male patient, 43 years of age, was diagnosed with dermatitis atopic and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: retinal detachment, retinopexy. NEORAL dosage: 100 MG, BID. Patient recovered.
NEORAL problem was reported by a Physician from JAPAN on Apr 03, 2007. Male patient, 56 years of age, was diagnosed with liver transplant and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: lung neoplasm malignant, pleural effusion. NEORAL dosage: 400 MG/D. During the same period patient was treated with METHYLPREDNISOLONE. Patient died on 02/20/2007.
Physician from UNITED STATES reported NEORAL problem on Apr 06, 2007. Male patient, weighting 142.2 lb, was diagnosed with prophylaxis against transplant rejection, cholelithiasis, anaemia, infection prophylaxis and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: cholangitis sclerosing, renal failure chronic. NEORAL dosage: unknown. During the same period patient was treated with ACTIGALL, ARANESP, BACTRIM DS. Patient was hospitalized. Patient recovered.
NEORAL problem was reported by a Physician from JAPAN on Apr 06, 2007. Male patient, 80 years of age, was diagnosed with interstitial lung disease and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: blood potassium increased, hepatic function abnormal, interstitial lung disease. NEORAL dosage: 150 MG/D. During the same period patient was treated with PREDONINE, GASTER, LASIX, WARFARIN. Patient died on 01/21/2007.
Physician from JAPAN reported NEORAL problem on Apr 05, 2007. Female patient, child 4 years of age, weighting 39.68 lb, was diagnosed with polyarteritis nodosa and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, agitation, atrioventricular block second degree, convulsion, depressed level of consciousness, encephalopathy, headache, hypertension. NEORAL dosage: 50 MG/D. During the same period patient was treated with PREDONINE, HERBESSER. Patient was hospitalized. Patient recovered.
NEORAL problem was reported by a Consumer or non-health professional from JAPAN on Apr 05, 2007. Female patient, 64 years of age, was diagnosed with stem cell transplant, graft versus host disease and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: blood lactate dehydrogenase increased, chronic graft versus host disease, glomerulonephritis, hypoalbuminaemia, nephrotic syndrome, oedema, pitting oedema, proteinuria, skin lesion. NEORAL dosage: unknown. During the same period patient was treated with PREDNISOLONE, METHYLPREDNISOLONE. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from JAPAN reported NEORAL problem on Apr 05, 2007. Male patient, child 8 years of age, weighting 92.59 lb, was diagnosed with nephrotic syndrome and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: blood albumin decreased, blood cholesterol increased, blood creatinine increased, blood urea increased, disease recurrence, eye pain, eyelid oedema, malaise. NEORAL dosage: unknown. Patient was hospitalized. Patient recovered.
NEORAL problem was reported by a Pharmacist from UNITED KINGDOM on Apr 05, 2007. Female patient was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: retinal haemorrhage. NEORAL dosage: 100 MG, BID. Patient recovered.
Consumer or non-health professional from FRANCE reported NEORAL problem on Apr 10, 2007. Female patient, 67 years of age, was diagnosed with renal transplant, hypothyroidism and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: adrenal insufficiency, apathy, asthenia, bacterial infection, blood creatinine increased, blood culture positive, blood thyroid stimulating hormone increased, blood urea increased, c-reactive protein increased. NEORAL dosage: unknown. During the same period patient was treated with CORTANCYL, LEVOTHYROXINE, LASIX, HYDROCORTISONE. Patient was hospitalized. Patient recovered.
NEORAL problem was reported by a Pharmacist from JAPAN on Apr 12, 2007. Male patient was diagnosed with rheumatoid arthritis and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: hallucination. NEORAL dosage: 75 MG DAILY. Patient recovered.
Physician from NETHERLANDS reported NEORAL problem on Apr 13, 2007. Male patient, 61 years of age, was diagnosed with renal transplant and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: hyperphosphataemia, pancreatitis. NEORAL dosage: 100MG ONCE A DAY, AND 75MG ONCE A DAY. Patient recovered.
NEORAL problem was reported by a Physician from JAPAN on Apr 12, 2007. Male patient, 84 years of age, was diagnosed with glomerulonephritis membranous and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: dehydration, dementia, listless, restlessness. NEORAL dosage: 75 MG DAILY. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from JAPAN reported NEORAL problem on Apr 18, 2007. Female patient, 57 years of age, was diagnosed with renal transplant and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, blood creatinine increased, brain neoplasm, brain oedema, chronic allograft nephropathy, headache, interleukin-2 receptor increased, lymphoma, neurological symptom. NEORAL dosage: unknown. During the same period patient was treated with AZANIN, PREDONINE, MYCOPHENOLATE MOFETIL. Patient died on 04/01/2006.
NEORAL problem was reported by a Consumer or non-health professional from JAPAN on Apr 18, 2007. Female patient, 57 years of age, was diagnosed with renal transplant and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, blood creatinine increased, brain neoplasm, brain oedema, chronic allograft nephropathy, headache, interleukin-2 receptor increased, lymphoma, neurological symptom. NEORAL dosage: unknown. During the same period patient was treated with AZANIN, PREDONINE, MYCOPHENOLATE MOFETIL. Patient died on 04/01/2006.
Consumer or non-health professional from JAPAN reported NEORAL problem on Apr 18, 2007. Female patient, child 1 years of age, was diagnosed with juvenile arthritis and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: cytomegalovirus infection, haemodialysis, histiocytosis haematophagic, pyrexia, rash. NEORAL dosage: unknown. During the same period patient was treated with METHYLPREDNISOLONE. Patient recovered.
NEORAL problem was reported by a Consumer or non-health professional from FRANCE on Apr 18, 2007. Female patient, 25 years of age, weighting 119.0 lb, was diagnosed with psoriasis and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: haematuria, microalbuminuria, proteinuria. NEORAL dosage: 200 MG, QD. Patient was hospitalized. Patient recovered.
Pharmacist from JAPAN reported NEORAL problem on Apr 19, 2007. Male patient was diagnosed with rheumatoid arthritis and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: hallucination. NEORAL dosage: 75 MG DAILY. During the same period patient was treated with MEDROL. Patient recovered.
NEORAL problem was reported by a Physician from JAPAN on Apr 19, 2007. Female patient, 44 years of age, weighting 132.3 lb, was diagnosed with systemic lupus erythematosus and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: blood pressure increased, epilepsy, gaze palsy, hypoaesthesia, loss of consciousness. NEORAL dosage: 50 MG/D. During the same period patient was treated with MEDROL, SUCRALFATE, ADALAT, TAGAMET, MIKELAN, OLMETEC. Patient recovered.
Physician from JAPAN reported NEORAL problem on Apr 24, 2007. Male patient, 69 years of age, was diagnosed with chronic inflammatory demyelinating polyradiculoneuropathy and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: aortic aneurysm, c-reactive protein increased, diarrhoea, malaise, pyrexia, salmonellosis, vomiting. NEORAL dosage: 50 MG/DAY. During the same period patient was treated with PREDONINE, BASEN, BONALON, CYANOCOBALAMIN, TOCOPHERYL NICOTINATE, GASTER D, PURSENNID, MAGNESIUM OXIDE. Patient was hospitalized. Patient recovered.
NEORAL problem was reported by a Consumer or non-health professional from JAPAN on Apr 24, 2007. Male patient, 13 years of age, was diagnosed with nephrotic syndrome and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: hypertensive encephalopathy, nephropathy, renal tubular atrophy. NEORAL dosage: 125 MG/D. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from JAPAN reported NEORAL problem on Apr 24, 2007. Male patient, 13 years of age, was diagnosed with nephrotic syndrome and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: hypertensive encephalopathy, nephropathy, renal tubular atrophy. NEORAL dosage: 125 MG/D. Patient was hospitalized. Patient recovered.
NEORAL problem was reported by a Consumer or non-health professional from JAPAN on May 09, 2007. Male patient, 75 years of age, was diagnosed with nephrotic syndrome and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: erythema, hepatic function abnormal, pain, rash, rash pustular, scedosporium infection, skin erosion. NEORAL dosage: unknown. During the same period patient was treated with STEROIDS NOS. Patient was hospitalized. Patient recovered.
Pharmacist from JAPAN reported NEORAL problem on May 09, 2007. Male patient, 52 years of age, weighting 127.9 lb, was diagnosed with haemophilia and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: back pain, blood bilirubin increased, blood creatinine increased, blood lactate dehydrogenase increased, blood urea increased, gastrointestinal haemorrhage, haemoglobin decreased, haemolytic uraemic syndrome. NEORAL dosage: 300 MG/D. During the same period patient was treated with PREDNISOLONE. Patient recovered.
NEORAL problem was reported by a Consumer or non-health professional from UNITED STATES on May 03, 2007. Male patient, 55 years of age, was diagnosed with renal transplant and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: proteinuria, renal failure acute. NEORAL dosage: 300 MG. During the same period patient was treated with CORTANCYL, CELLCEPT. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from JAPAN reported NEORAL problem on May 09, 2007. Male patient, 45 years of age, was diagnosed with pemphigus and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: nocardiosis. NEORAL dosage: unknown. Patient died.
NEORAL problem was reported by a Physician from UNITED KINGDOM on May 09, 2007. Female patient, 37 years of age, weighting 211.6 lb, was diagnosed with eczema and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: lower respiratory tract infection, pneumonitis. NEORAL dosage: 150MG / DAY. During the same period patient was treated with AZATHIOPRINE. Patient was hospitalized. Patient died on 11/20/2006.
Consumer or non-health professional from JAPAN reported NEORAL problem on May 08, 2007. Male patient, 28 years of age, was diagnosed with nephrotic syndrome and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, focal glomerulosclerosis, low density lipoprotein apheresis, nausea, palpitations, proteinuria, renal impairment. NEORAL dosage: 150 MG/D. During the same period patient was treated with PREDONINE. Patient recovered.
NEORAL problem was reported by a Physician from JAPAN on May 10, 2007. Male patient, 84 years of age, weighting 114.6 lb, was diagnosed with glomerulonephritis membranous and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, amnesia, anaemia, decreased appetite, dehydration, dementia, depressed level of consciousness, haematemesis, haematocrit decreased. NEORAL dosage: 100 MG/D. During the same period patient was treated with BREDININ, CONIEL, ATELEC, ADALAT, FIRSTCIN, BAKTAR, ASPIRIN. Patient was hospitalized. Patient died on 05/01/2007.
Physician from ARGENTINA reported NEORAL problem on May 09, 2007. Male patient, 60 years of age, weighting 176.4 lb, was diagnosed with liver transplant and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: confusional state, delirium, hallucination, visual, mental status changes. NEORAL dosage: 900 MG DAILY. Patient was hospitalized. Patient recovered.
NEORAL problem was reported by a Physician from BELGIUM on May 15, 2007. Male patient, 70 years of age, was diagnosed with heart transplant and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: anuria, bronchitis, dialysis, interstitial lung disease, nephropathy toxic, renal failure chronic. NEORAL dosage: unknown. Patient was hospitalized. Patient died on 11/16/2006.
Consumer or non-health professional from JAPAN reported NEORAL problem on May 16, 2007. Male patient, 45 years of age, was diagnosed with smallpox and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: bronchoalveolar lavage, nocardiosis, nodule, pleural disorder. NEORAL dosage: unknown. During the same period patient was treated with STEROIDS NOS. Patient died.
NEORAL problem was reported by a Consumer or non-health professional from JAPAN on May 16, 2007. Female patient, child 12 years of age, was diagnosed with nephrotic syndrome and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: coagulopathy, deep vein thrombosis, diplopia, disease progression, headache, nephrotic syndrome, peritoneal dialysis, proteinuria, renal failure acute. NEORAL dosage: unknown. During the same period patient was treated with STEROIDS NOS. Patient was hospitalized and became disabled. Patient recovered.
Consumer or non-health professional from JAPAN reported NEORAL problem on May 16, 2007. Female patient, child 12 years of age, was diagnosed with nephrotic syndrome and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: coagulopathy, deep vein thrombosis, diplopia, disease progression, headache, nephrotic syndrome, peritoneal dialysis, proteinuria, renal failure acute. NEORAL dosage: unknown. During the same period patient was treated with STEROIDS NOS. Patient was hospitalized and became disabled. Patient recovered.
NEORAL problem was reported by a Consumer or non-health professional from JAPAN on May 16, 2007. Female patient, 30 years of age, was diagnosed with nephrotic syndrome and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, condition aggravated, nephrotic syndrome. NEORAL dosage: 300 MG/DAY. During the same period patient was treated with MIZORIBINE, PREDNISOLONE. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from JAPAN reported NEORAL problem on May 21, 2007. Male patient, 45 years of age, was diagnosed with pemphigus, smallpox and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: bronchoalveolar lavage, cytomegalovirus infection, multi-organ failure, nocardiosis, nodule, pleural disorder, pneumocystis jiroveci pneumonia. NEORAL dosage: unknown. During the same period patient was treated with STEROIDS NOS. Patient died.
NEORAL problem was reported by a Physician from UNITED KINGDOM on May 22, 2007. Female patient, weighting 154.3 lb, was diagnosed with immunosuppression, glaucoma, restless legs syndrome, hypertension, hypercholesterolaemia, prophylaxis against gastrointestinal ulcer, angina pectoris, left ventricular failure and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: blood calcium decreased, chronic allograft nephropathy, dehydration, diarrhoea, hypokalaemia, lower respiratory tract infection, syncope, white blood cell count decreased. NEORAL dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, TRAVOPROST, GABAPENTIN, ATENOLOL, PRAVASTATIN, OMEPRAZOLE, ISOSORBIDE MONONITRATE, ISOSORBIDE MONONITRATE. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported NEORAL problem on May 16, 2007. Female patient, 51 years of age, was diagnosed with renal transplant and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: glomerulosclerosis, kidney transplant rejection, nephrectomy, nephrotic syndrome, proteinuria, renal tubular necrosis. NEORAL dosage: 250 MG/DAILY. During the same period patient was treated with CELLCEPT, CORTANCYL, BACTRIM. Patient was hospitalized. Patient recovered.
NEORAL problem was reported by a Consumer or non-health professional from JAPAN on May 23, 2007. Female patient, 62 years of age, was diagnosed with renal transplant and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: jc virus infection, progressive multifocal leukoencephalopathy. NEORAL dosage: 5 MG/KG/D. During the same period patient was treated with CELLCEPT, PREDONINE. Patient died on 01/01/2006.
Physician from JAPAN reported NEORAL problem on May 21, 2007. Male patient, 16 years of age, was diagnosed with nephrotic syndrome and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: nephropathy, nephrotic syndrome, therapeutic response decreased. NEORAL dosage: 100 MG/DAY. Patient recovered.
NEORAL problem was reported by a Physician from BELGIUM on May 27, 2007. Male patient, 70 years of age, was diagnosed with heart transplant and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: anuria, bronchitis, dialysis, gastroenteritis viral, interstitial lung disease, nephropathy toxic, renal failure chronic. NEORAL dosage: unknown. During the same period patient was treated with CERTICAN. Patient was hospitalized. Patient died on 11/16/2006.
Physician from JAPAN reported NEORAL problem on May 24, 2007. Male patient, 73 years of age, was diagnosed with psoriasis and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: dizziness, fall. NEORAL dosage: 100 MG/D. Patient recovered.
NEORAL problem was reported by a Physician from UNITED STATES on May 29, 2007. Male patient, 54 years of age, was diagnosed with renal and pancreas transplant and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: astrocytoma, blood creatinine increased, chills, demyelinating polyneuropathy, diabetes mellitus, feeling cold, hypoaesthesia, kidney transplant rejection. NEORAL dosage: 50 MG, BID. During the same period patient was treated with IMURAN, PREDNISONE, VYTORIN, ASPIRIN, SYNTHROID, CLONIDINE, LYRICA. Patient was hospitalized. Patient recovered.
Pharmacist from JAPAN reported NEORAL problem on May 25, 2007. Male patient, child 4 years of age, was diagnosed with nephrotic syndrome, nasopharyngitis and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: confusional state, psychiatric symptom. NEORAL dosage: unknown. During the same period patient was treated with TAVEGYL, PERIACTIN. Patient recovered.
NEORAL problem was reported by a Consumer or non-health professional from JAPAN on June 05, 2007. Male patient, 62 years of age, was diagnosed with stem cell transplant and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease, diarrhoea, diffuse alveolar damage, headache, immunodeficiency, mass, multi-organ failure, nodule, olfactory nerve disorder. NEORAL dosage: unknown. During the same period patient was treated with METHYLPREDNISOLONE, TACROLIMUS, RITUXAN, CYCLOPHOSPHAMIDE, NOVANTRONE, ONCOVIN, PREDNISONE. Patient was hospitalized. Patient died.
Consumer or non-health professional from JAPAN reported NEORAL problem on June 05, 2007. Male patient, 62 years of age, was diagnosed with stem cell transplant and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease, diarrhoea, diffuse alveolar damage, headache, immunodeficiency, mass, multi-organ failure, nodule, olfactory nerve disorder. NEORAL dosage: unknown. During the same period patient was treated with METHYLPREDNISOLONE, TACROLIMUS, RITUXAN, CYCLOPHOSPHAMIDE, NOVANTRONE, ONCOVIN, PREDNISONE. Patient was hospitalized. Patient died.
NEORAL problem was reported by a Consumer or non-health professional from JAPAN on June 04, 2007. Female patient, 62 years of age, was diagnosed with renal transplant and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: acalculia, agnosia, agraphia, alexia, aphasia, apraxia, central nervous system necrosis, depressed level of consciousness, dysstasia. NEORAL dosage: 5 MG/KG/D. During the same period patient was treated with CELLCEPT, PREDONINE. Patient died on 01/01/2006.
Consumer or non-health professional from JAPAN reported NEORAL problem on May 31, 2007. Male patient was diagnosed with psoriasis and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: blood glucose increased, cerebral infarction, duodenal polyp, dyspepsia, myocardial infarction. NEORAL dosage: 200 MG/DAY. Patient recovered.
NEORAL problem was reported by a Physician from AUSTRALIA on June 08, 2007. Male patient, 52 years of age, was diagnosed with renal transplant and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: brain stem haemorrhage, metastases to central nervous system, metastases to liver, metastatic malignant melanoma. NEORAL dosage: unknown. During the same period patient was treated with PREDNISOLONE. Patient was hospitalized and became disabled. Patient died on 06/09/2007.
Physician from JAPAN reported NEORAL problem on June 05, 2007. Male patient, 80 years of age, was diagnosed with pemphigoid and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: cholangitis, white blood cell count decreased. NEORAL dosage: 2 ML/DAY. During the same period patient was treated with PREDNISOLONE, URSO. Patient was hospitalized. Patient recovered.
NEORAL problem was reported by a Physician from JAPAN on June 07, 2007. Female patient, child 10 years of age, was diagnosed with nephrotic syndrome and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: convulsion, depressed level of consciousness, disease recurrence, headache, nephrotic syndrome, paralysis, toxic induced encephalopathy. NEORAL dosage: unknown. During the same period patient was treated with ADRENOCORTICOTROPHIC HORMONE, PREDNISOLONE. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported NEORAL problem on June 08, 2007. Male patient, 26 years of age, was diagnosed with renal transplant and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, blood lactate dehydrogenase increased, liver function test abnormal, platelet count decreased, red blood cell schistocytes present, urine output decreased. NEORAL dosage: 400 MG, QD. During the same period patient was treated with MYCOPHENOLATE MOFETIL, PREDNISOLONE, PANTOPRAZOLE. Patient recovered.
NEORAL problem was reported by a Consumer or non-health professional from JAPAN on June 13, 2007. Female patient, 65 years of age, was diagnosed with myelodysplastic syndrome and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: cerebral infarction, thrombotic microangiopathy, transfusion-related acute lung injury. NEORAL dosage: 6 MG/KG/DAY. During the same period patient was treated with ATGAM, PREDNISOLONE, NEUPOGEN. Patient was hospitalized. Patient died on 01/07/2007.
Consumer or non-health professional from JAPAN reported NEORAL problem on June 13, 2007. Female patient, 65 years of age, was diagnosed with myelodysplastic syndrome and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: cerebral infarction, thrombotic microangiopathy, transfusion-related acute lung injury. NEORAL dosage: 6 MG/KG/DAY. During the same period patient was treated with ATGAM, PREDNISOLONE, NEUPOGEN. Patient was hospitalized. Patient died on 01/07/2007.
NEORAL problem was reported by a Consumer or non-health professional from JAPAN on June 11, 2007. Female patient, 34 years of age, was diagnosed with renal transplant and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: abortion missed, benign hydatidiform mole, blood human chorionic gonadotropin increased, choriocarcinoma, fallopian tube obstruction, post procedural haemorrhage, uterine dilation and curettage. NEORAL dosage: 150 MG/DAY. During the same period patient was treated with IMURAN, PREDNISOLONE. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from JAPAN reported NEORAL problem on June 11, 2007. Male patient, child 11 years of age, was diagnosed with nephrotic syndrome and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: focal glomerulosclerosis, nephropathy toxic, tubulointerstitial nephritis. NEORAL dosage: unknown. Patient recovered.
NEORAL problem was reported by a Consumer or non-health professional from JAPAN on June 11, 2007. Male patient, child 8 years of age, was diagnosed with nephrotic syndrome and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: focal glomerulosclerosis, nephropathy toxic, tubulointerstitial nephritis. NEORAL dosage: unknown. Patient recovered.
Consumer or non-health professional from UNITED KINGDOM reported NEORAL problem on June 20, 2007. Female patient, 61 years of age, was diagnosed with renal transplant and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: cough, hyperglycaemia. NEORAL dosage: 50 MG, BID. During the same period patient was treated with MYCOPHENOLATE MOFETIL, PREDNISONE. Patient died on 06/01/2005.
NEORAL problem was reported by a Physician from BELGIUM on June 13, 2007. Male patient, 30 years of age, weighting 122.8 lb, was diagnosed with renal transplant and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: hypercalcaemia, overdose, parathyroidectomy, renal impairment. NEORAL dosage: 200 MG, BID. During the same period patient was treated with MEDROL, VALCYTE, BACTRIM, AMLOR, SELOZOK, MOXON, RIVOTRIL, ACEDICON. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from JAPAN reported NEORAL problem on June 20, 2007. Male patient, 15 years of age, weighting 72.75 lb, was diagnosed with chronic graft versus host disease and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, anxiety, blister, c-reactive protein increased, cholecystitis chronic, depressed level of consciousness, disseminated intravascular coagulation, gastritis, haemorrhage. NEORAL dosage: 25 MG/D. During the same period patient was treated with CYCLOPHOSPHAMIDE, CYTARABINE, FLUDARABINE, MELPHALAN, TACROLIMUS, METHOTREXATE, PREDNISOLONE, PENTAZOCINE LACTATE. Patient was hospitalized. Patient died on 07/17/2004.
NEORAL problem was reported by a Consumer or non-health professional from JAPAN on June 20, 2007. Male patient, 15 years of age, weighting 72.75 lb, was diagnosed with chronic graft versus host disease and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, anxiety, blister, c-reactive protein increased, cholecystitis chronic, depressed level of consciousness, disseminated intravascular coagulation, gastritis, haemorrhage. NEORAL dosage: 25 MG/D. During the same period patient was treated with CYCLOPHOSPHAMIDE, CYTARABINE, FLUDARABINE PHOSPHATE, MELPHALAN, TACROLIMUS, METHOTREXATE, PREDNISOLONE, PENTAZOCINE LACTATE. Patient was hospitalized. Patient died on 07/17/2004.
Consumer or non-health professional from JAPAN reported NEORAL problem on June 21, 2007. Female patient, 64 years of age, was diagnosed with nephrotic syndrome and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: blister, cryptococcosis, erythema, hepatitis b, necrosis, pancreatitis, pneumonia, skin disorder. NEORAL dosage: 60 MG/D. During the same period patient was treated with PREDNISOLONE. Patient was hospitalized. Patient died.
NEORAL problem was reported by a Consumer or non-health professional from JAPAN on June 21, 2007. Female patient, 64 years of age, was diagnosed with nephrotic syndrome and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: blister, cryptococcosis, erythema, hepatitis b, necrosis, pancreatitis, pneumonia, skin disorder. NEORAL dosage: 60 MG/D. During the same period patient was treated with PREDNISOLONE. Patient was hospitalized. Patient died.
Consumer or non-health professional from JAPAN reported NEORAL problem on June 15, 2007. Female patient, 63 years of age, was diagnosed with renal transplant and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, kidney transplant rejection, pancytopenia, viral infection. NEORAL dosage: unknown. During the same period patient was treated with CELLCEPT, MEDROL. Patient was hospitalized. Patient recovered.
NEORAL problem was reported by a Health Professional from FRANCE on June 20, 2006. Male patient, 61 years of age, was diagnosed with liver transplant and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, anaemia, aspartate aminotransferase increased, blood creatinine increased, blood urea increased, ecchymosis, epistaxis, haemoglobin decreased, rash macular. NEORAL dosage: 50 MG, BID. During the same period patient was treated with PREDNISONE. Patient recovered.
Consumer or non-health professional from FRANCE reported NEORAL problem on July 03, 2006. Male patient, 44 years of age, was diagnosed with graft versus host disease and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, phlebitis, renal failure. NEORAL dosage: unknown. During the same period patient was treated with CELLCEPT. Patient was hospitalized. Patient recovered.
NEORAL problem was reported by a Physician from CHINA on July 26, 2005. Male patient, 66 years of age, weighting 154.3 lb, was diagnosed with renal transplant and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: life support, lung infection, pyrexia, respiratory failure. NEORAL dosage: 100 MG, BID. Patient was hospitalized. Patient died on 07/21/2005.
Consumer or non-health professional from ARGENTINA reported NEORAL problem on June 23, 2006. Male patient, 28 years of age, was diagnosed with prophylaxis against transplant rejection and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: cytomegalovirus infection, white blood cell count decreased. NEORAL dosage: 350 MG 1X PER 1 DAY, ORAL. During the same period patient was treated with MYCOPHENOLATE MOFETIL, PREDNISONE, ACYCLOVIR, BACTRIM DS, PANTOPRAZOLE. Patient was hospitalized. Patient recovered.
NEORAL problem was reported by a Physician from on June 28, 2006. Female patient, 30 years of age, was diagnosed with psoriasis and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: ageusia, visual disturbance, weight decreased. NEORAL dosage: 5 MG/KG, QD. Patient recovered.
Physician from FRANCE reported NEORAL problem on June 20, 2006. Male patient, 61 years of age, was diagnosed with liver transplant and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, anaemia, aspartate aminotransferase increased, ecchymosis, epistaxis, haemoglobin decreased, hyperkeratosis, rash macular, renal failure. NEORAL dosage: 50 MG, BID, UNK. During the same period patient was treated with PREDNISONE. Patient recovered.
NEORAL problem was reported by a Physician from VENEZUELA on June 15, 2006. Female patient, 39 years of age, weighting 92.59 lb, was diagnosed with transplant and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: abdominal pain, intestinal obstruction. NEORAL dosage: 150 MG, QD. During the same period patient was treated with METICORTEN, IMURAN. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from ARGENTINA reported NEORAL problem on June 28, 2006. Male patient, 24 years of age, was diagnosed with prophylaxis against transplant rejection and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: kidney transplant rejection, renal tubular necrosis. NEORAL dosage: unknown. During the same period patient was treated with OMEPRAZOLE, SULFAMETHOXAZOLE. Patient was hospitalized. Patient recovered.
NEORAL problem was reported by a Consumer or non-health professional from FRANCE on July 06, 2006. Male patient, 65 years of age, was diagnosed with prophylaxis against transplant rejection and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: cholestasis, hepatotoxicity. NEORAL dosage: 100 MG DAILY AT THE TIME OF THE EVENT ONSET. During the same period patient was treated with CELLCEPT, CORTANCYL. Patient recovered.
Physician from JAPAN reported NEORAL problem on July 03, 2006. Male patient, 56 years of age, was diagnosed with liver transplant and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: multi-organ failure, post procedural complication. NEORAL dosage: 500 MG/D. Patient died on 07/02/2006.
Showing 1-75 of 379 Next >